ATEC – Alphatec Holdings, Inc.

Alphatec Holdings, Inc.

ATEC

$7.00

Name : Alphatec Holdings, Inc.

Sector : Healthcare

Industry: Medical Devices

Mark. Cap: $1,073,322,752.00

EPSttm : -0.57

Alphatec Holdings, Inc.

$7.00

5.15%

$0.38

ATEC — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

10.95

Margin Of Safety %

Put/Call OI Ratio

0.31

EPS Next Q Diff

0.02

EPS Last/This Y

0.24

EPS This/Next Y

0.27

Price

Target Price

13.29

Analyst Recom

1.29

Performance Q

-27.31

Upside

-380.0%

Beta

0.87

Ticker: ATEC

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-12	ATEC	11.26	0.28	0.31	16372
2026-10-13	ATEC	10.82	0.29	0.23	16301
2026-10-14	ATEC	10.48	0.30	0.65	16148
2026-10-15	ATEC	10.97	0.30	0.03	16171
2026-10-16	ATEC	10.47	0.30	0.02	16168
2026-10-19	ATEC	10.41	0.27	5.08	13073
2026-10-20	ATEC	10.85	0.29	0.00	13361
2026-10-21	ATEC	10.86	0.29	8.00	13340
2026-10-22	ATEC	11.35	0.30	0.78	13426
2026-10-23	ATEC	11.1	0.31	0.01	13241
2026-10-26	ATEC	10.89	0.32	0.07	12718
2026-10-27	ATEC	10.86	0.32	33.33	12766
2026-10-28	ATEC	11.45	0.34	0.59	12963
2026-10-29	ATEC	11.38	0.36	1.45	13108
2026-10-30	ATEC	7.04	0.45	3.36	14305
2026-11-02	ATEC	7.32	0.34	0.16	13654
2026-11-03	ATEC	7.49	0.32	0.02	14054
2026-11-04	ATEC	8.28	0.32	0.02	14277
2026-11-05	ATEC	7.78	0.32	0.67	14279
2026-11-06	ATEC	7.44	0.31	0.95	14234
2026-11-09	ATEC	7.37	0.31	1.16	14250
2026-11-10	ATEC	6.99	0.31	4.16	14296
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-12	ATEC	11.25	213.4	-	0.33
2026-10-13	ATEC	10.84	213.4	-	0.33
2026-10-14	ATEC	10.45	213.4	-	0.33
2026-10-15	ATEC	10.93	213.4	-	0.33
2026-10-16	ATEC	10.46	213.4	-	0.33
2026-10-19	ATEC	10.41	213.4	-	0.33
2026-10-20	ATEC	10.41	213.4	-	0.33
2026-10-21	ATEC	10.85	213.4	-	0.33
2026-10-22	ATEC	11.35	213.4	-	0.33
2026-10-23	ATEC	11.10	213.4	-	0.33
2026-10-26	ATEC	10.90	206.0	-	0.33
2026-10-27	ATEC	10.86	206.0	-	0.33
2026-10-28	ATEC	11.45	206.0	-	0.33
2026-10-29	ATEC	11.39	206.0	-	0.33
2026-10-30	ATEC	7.05	206.0	-	0.33
2026-11-02	ATEC	7.31	135.5	-	0.33
2026-11-03	ATEC	7.47	135.5	-	0.30
2026-11-04	ATEC	8.29	135.5	-	0.30
2026-11-05	ATEC	7.78	135.5	-	0.30
2026-11-06	ATEC	7.43	105.0	-	0.29
2026-11-09	ATEC	7.38	105.0	-	0.29
2026-11-10	ATEC	7.00	105.0	-	0.29
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-12	ATEC	0.71	-0.97	11.65
2026-10-13	ATEC	0.71	-0.97	11.65
2026-10-14	ATEC	0.71	-0.97	11.65
2026-10-15	ATEC	0.71	-0.97	11.65
2026-10-16	ATEC	0.71	-0.97	11.65
2026-10-19	ATEC	0.71	-0.69	11.65
2026-10-20	ATEC	0.71	-0.69	11.65
2026-10-21	ATEC	0.71	-0.69	11.65
2026-10-22	ATEC	0.71	-0.69	11.65
2026-10-23	ATEC	0.71	-0.69	11.65
2026-10-26	ATEC	0.71	-0.59	11.65
2026-10-27	ATEC	0.71	-0.59	11.00
2026-10-28	ATEC	0.71	-0.59	11.00
2026-10-29	ATEC	0.71	-0.59	11.00
2026-10-30	ATEC	0.71	-0.59	11.00
2026-11-02	ATEC	0.88	-0.66	10.95
2026-11-03	ATEC	0.88	-0.66	10.95
2026-11-05	ATEC	0.88	-0.66	10.95
2026-11-06	ATEC	0.88	-0.66	10.95
2026-11-09	ATEC	0.88	-0.65	10.95
2026-11-10	ATEC	0.88	-0.65	10.95
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

0.04

Avg. EPS Est. Current Quarter

0.12

Avg. EPS Est. Next Quarter

0.06

Insider Transactions

0.88

Institutional Transactions

-0.65

Beta

0.87

Average Sales Estimate Current Quarter

236

Average Sales Estimate Next Quarter

226

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

69.9

Max Drawdown 5-Year %

-73.5

Target Price

13.29

P/E

Forward P/E

12.43

PEG

0.08

P/S

1.29

P/B

P/Free Cash Flow

353.74

EPS

-0.56

Average EPS Est. Cur. Y

0.29

EPS Next Y. (Est.)

0.56

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-10.35

Relative Volume

1.52

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.03

EBIT Estimation

◆ ATEC Healthcare

$7.00

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

13/25

Volume

0/15

Valuation

15/20

TP/AR

2/10

Options

4/10

RSI

32.2

Range 1M

🚀

Momentum Growth

Ride accelerating trends

N/A

WATCH

Momentum

18/25

Growth

28/30

Estimates

2/20

Inst/Vol

3/15

Options

6/10

EPS Yr

488.3%

EPS NY

91.5%

52W%

0.6%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +154.3% upside

Quality

6/30

Valuation

21/30

Growth

20/25

Stability

4/10

LT Trend

4/5

Upside

+154.3%

Quality

ATEC — P/E HistoricalMedical Devices

Alphatec Holdings, Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 913

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissue; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. The company was founded in 1990 and is headquartered in Carlsbad, California.

ATEC

Latest News

—

Caricamento notizie per ATEC…

stock quote shares ATEC – Alphatec Holdings, Inc. Stock Price stock today

news today ATEC – Alphatec Holdings, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ATEC – Alphatec Holdings, Inc. yahoo finance google finance

stock history ATEC – Alphatec Holdings, Inc. invest stock market

stock prices ATEC premarket after hours

ticker ATEC fair value insiders trading

ATEC – Alphatec Holdings, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ATEC

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y